Review highlights diagnostic and therapeutic strategies for neonatal sepsis and septic shock, suggesting improved outcomes through individualized care.
Key Points
This review examines the evolving management strategies for neonatal sepsis and septic shock, emphasizing the incorporation of new diagnostic tools and individualized care.
Discussion of various biomarkers for diagnosis and management, including C-reactive protein and procalcitonin.
Evaluation of imaging techniques like targeted neonatal echocardiography and point-of-care ultrasound to guide resuscitation.
Exploration of machine learning models for diagnostic performance and their limitations.
Biomarkers display limitations despite diagnostic utility for neonatal sepsis and septic shock.